Vir Biotechnology, Inc.
VIR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001706431
No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Vir Biotechnology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Vir Biotechnology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| More Robert J | Director | 517,917Indirect | Aug 12, 2026 | 2 |
| Coughlin Timothy | Director | 16,000 | Jun 10, 2026 | 1 |
| Napolitano Janet | Director | 21,216 | Jun 2, 2026 | 2 |
| Sabatini Brent | SVP, Chief Accounting Officer | 61,902 | Jun 2, 2026 | 5 |
| Bischofberger Norbert W | Director | 21,333 | May 28, 2026 | 1 |
| Hatfield Jeffrey S. | Director | 39,806 | May 28, 2026 | 1 |
| Sigal Charles Elliott | Director | 39,806 | May 28, 2026 | 1 |
| Farid Ramy | Director | 32,000 | May 28, 2026 | 1 |
| Sato Vicki L | Director | 1,078,391 | May 4, 2026 | 9 |
| De Backer Marianne | President and CEO | 286,650Indirect | Apr 30, 2026 | 4 |
| O'Byrne Jason | EVP & Chief Financial Officer | 2,500Indirect | Mar 23, 2026 | 4 |
| Eisner Mark | EVP and Chief Medical Officer | 154,024 | Feb 26, 2026 | 2 |
| de Verneuil Vanina | EVP, General Counsel, Corp Sec | 112,982 | Feb 26, 2026 | 4 |
| SB Investment Advisers (UK) Ltd | 10% Owner | 13,728,924Indirect | Dec 3, 2025 | 11 |
| Softbank Vision Fund (Aiv M1) L.P. | 10% Owner | 13,728,924Indirect | Dec 3, 2025 | 11 |
| SVF Endurance (Cayman) Ltd | 10% Owner | 13,728,924Indirect | Dec 3, 2025 | 11 |
| Ramasastry Saira | Director | 22,619 | Jun 2, 2025 | 0 |
| Scangos George A | Director | 698,239 | Feb 25, 2025 | 0 |
| Hanly Ann M. | EVP & Chief Technology Officer | 117,901 | Feb 25, 2025 | 0 |
| Nelsen Robert | Director | 584,148 | Jun 3, 2024 | 0 |
| Lee Sung | EVP & Chief Financial Officer | 100,492 | Mar 28, 2024 | 0 |
| Pang Phillip | EVP & Chief Medical Officer | 250,111 | Feb 26, 2024 | 0 |
| Rice Steven J. | Chief Administrative Officer | 106,840 | Jun 2, 2023 | 0 |
| Sharp Phillip A | Director | 121,174 | May 24, 2023 | 0 |
| Perez Robert J | Director | 15,806 | May 24, 2023 | 0 |
| Friedl-Naderer Johanna | EVP & Chief Operating Officer | 148,518 | Mar 7, 2023 | 0 |
| Horn Howard | CFO | 230,712 | Feb 24, 2023 | 0 |
| Crandell Keith | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| Bybee Clinton | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| ARCH Venture Fund IX, L.P. | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| ARCH Venture Fund IX Overage, L.P. | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| ARCH Venture Partners IX Overage, L.P. | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| ARCH Venture Partners IX, L.P. | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| ARCH Venture Partners IX, LLC | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| Virgin Herbert | EVP, Research & CSO | 262,500 | Aug 10, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2022 (view filing) | Feb 17 | 5 days | Horn HowardCFO | SSale | −2.39K | $31.93 | −$76.4K | −1.2%200.4K after | |
| Feb 22, 2022 (view filing) | Feb 17 | 5 days | Rice Steven J.Chief Administrative Officer | SSale | −1.94K | $31.93 | −$62.0K | −9.4%18.7K after | |
| Feb 22, 2022 (view filing) | Feb 17 | 5 days | Virgin HerbertEVP, Research & CSO | SSale | −2.29K | $31.93 | −$73.2K | −2.1%105.4K after | |
| Feb 22, 2022 (view filing) | Feb 17-18 | 5 days | Scangos George APresident and CEO | SSale | −27.8K | $31.11 | −$863.4K | −19.7%113.0K after | 2 lots |
| Feb 24, 2022 (view filing) | Feb 22 | 2 days | Virgin HerbertEVP, Research & CSO | SSale | −1.38K | $30.00 | −$41.3K | −0.8%175.4K after | |
| Mar 31, 2022 (view filing) | Mar 30 | 1 day | Hanly Ann M.Chief Technology Officer | SSale | −2.63K | $26.24 | −$68.9K | −3.1%81.5K after | |
| May 2, 2022 (view filing) | Apr 28 | 4 days | Sato Vicki LDirector | SSale | −17.9K | $20.90 | −$374.4K | −1.2%1.52M after | 2 lots |
| May 10, 2022 (view filing) | May 9 | 1 day | Sato Vicki LDirector | SSale | −14.5K | $20.62 | −$299.8K | −1.0%1.50M after | |
| May 25, 2022 (view filing) | May 24 | 1 day | Ramasastry SairaDirector | SSale | −1.69K | $23.82 | −$40.2K | −17.3%8.09K after | |
| May 25, 2022 (view filing) | May 24 | 1 day | Sato Vicki LDirector | SSale | −3.37K | $23.82 | −$80.4K | −0.2%1.51M after | |
| Jun 9, 2022 (view filing) | Jun 8 | 1 day | Sato Vicki LDirector | SSale | −17.9K | $25.84 | −$462.9K | −1.2%1.49M after | 2 lots |
| Jun 22, 2022 (view filing) | Jun 21 | 1 day | Pang PhillipChief Medical Officer | SSale | −4.99K | $24.89 | −$124.2K | −3.3%144.0K after | |
| Jul 12, 2022 (view filing) | Jul 8 | 4 days | Sato Vicki LDirector | SSale | −17.9K | $29.07 | −$520.8K | −1.2%1.47M after | 2 lots |
| Jul 13, 2022 (view filing) | Jul 11 | 2 days | Ramasastry SairaDirector | SSale | −5.00K | $30.00 | −$150.0K | −38.2%8.09K after | |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Pang PhillipChief Medical Officer | SSale | −5.00K | $30.00 | −$150.0K | −3.4%144.0K after | |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Sato Vicki LDirector | SSale | −17.9K | $30.29 | −$542.6K | −1.2%1.45M after | |
| Aug 17, 2022 (view filing)4:53 PM ET | Aug 15-16 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −130.4K | $27.97 | −$3.65M | −0.6%22.1M after | 3 lots |
| Sep 9, 2022 (view filing) | Sep 8 | 1 day | Sato Vicki LDirector | SSale | −17.9K | $21.90 | −$392.3K | −1.2%1.43M after | |
| Oct 11, 2022 (view filing) | Oct 10 | 1 day | Sato Vicki LDirector | SSale | −17.9K | $20.67 | −$370.3K | −1.2%1.42M after | |
| Nov 9, 2022 (view filing) | Nov 8 | 1 day | Sato Vicki LDirector | SSale | −17.9K | $27.38 | −$490.5K | −1.3%1.40M after | |
| Nov 9, 2022 (view filing)4:30 PM ET | Nov 7-8 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −182.1K | $27.26 | −$4.96M | −0.8%21.9M after | 2 lots |
| Nov 14, 2022 (view filing)4:31 PM ET | Nov 9-11 | 5 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −287.7K | $27.31 | −$7.86M | −1.3%21.6M after | 3 lots |
| Nov 16, 2022 (view filing)9:00 PM ET | Nov 14-15 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −138.0K | $27.61 | −$3.81M | −0.6%21.5M after | 3 lots |
| Nov 18, 2022 (view filing)4:30 PM ET | Nov 16-17 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −210.0K | $27.41 | −$5.76M | −1.0%21.3M after | 3 lots |
| Nov 22, 2022 (view filing)6:00 PM ET | Nov 18-21 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −26.0K | $27.21 | −$706.8K | −0.1%21.2M after | 2 lots |
| Nov 23, 2022 (view filing)4:30 PM ET | Nov 22 | 1 day | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −65.2K | $27.27 | −$1.78M | −0.3%21.2M after | |
| Nov 28, 2022 (view filing)5:04 PM ET | Nov 23-25 | 5 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −57.0K | $27.27 | −$1.55M | −0.3%21.1M after | 2 lots |
| Nov 30, 2022 (view filing)8:50 PM ET | Nov 28-29 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −109.1K | $27.41 | −$2.99M | −0.5%21.0M after | 3 lots |
| Dec 2, 2022 (view filing)5:51 PM ET | Nov 30-Dec 1 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −212.3K | $27.77 | −$5.90M | −1.0%20.8M after | 4 lots |
| Dec 6, 2022 (view filing)9:30 PM ET | Dec 2-5 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −97.3K | $27.45 | −$2.67M | −0.5%20.7M after | 2 lots |
| Dec 9, 2022 (view filing) | Dec 8 | 1 day | Sato Vicki LDirector | SSale | −17.9K | $25.81 | −$462.4K | −1.3%1.38M after | |
| Dec 22, 2022 (view filing)9:00 PM ET | Dec 20-21 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −215.8K | $25.84 | −$5.58M | −1.0%20.5M after | 3 lots |
| Dec 27, 2022 (view filing)9:00 PM ET | Dec 22-23 | 5 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −175.2K | $25.93 | −$4.54M | −0.9%20.3M after | 4 lots |
| Dec 29, 2022 (view filing)9:00 PM ET | Dec 27 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −6.85K | $25.59 | −$175.3K | 0.0%20.3M after | |
| Jan 3, 2023 (view filing)9:00 PM ET | Dec 29, 2022 | 5 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −44.2K | $25.55 | −$1.13M | −0.2%20.3M after | |
| Jan 5, 2023 (view filing) | Jan 3-4 | 2 days | Sigal Charles ElliottDirector | PPurchase | +5.00K | $25.43 | +$127.1K | New position5.00K after | 2 lots |
| Jan 5, 2023 (view filing)9:00 PM ET | Jan 3-4 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −9.18K | $25.57 | −$234.6K | 0.0%20.3M after | 2 lots |
| Jan 9, 2023 (view filing) | Jan 5 | 4 days | Sigal Charles ElliottDirector | PPurchase | +2.50K | $24.96 | +$62.4K | +50.0%7.50K after | |
| Jan 10, 2023 (view filing)9:00 PM ET | Jan 6-9 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −101.0K | $26.03 | −$2.63M | −0.5%20.1M after | 4 lots |
| Jan 11, 2023 (view filing) | Jan 9 | 2 days | Sato Vicki LDirector | SSale | −17.9K | $25.83 | −$462.7K | −1.3%1.36M after | |
| Jan 12, 2023 (view filing)9:00 PM ET | Jan 10-11 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −149.6K | $26.32 | −$3.94M | −0.7%20.0M after | 3 lots |
| Jan 17, 2023 (view filing)9:00 PM ET | Jan 12-13 | 5 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −211.7K | $26.58 | −$5.63M | −1.1%19.8M after | 3 lots |
| Jan 19, 2023 (view filing)9:00 PM ET | Jan 17-18 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −190.8K | $26.28 | −$5.02M | −1.0%19.6M after | 2 lots |
| Jan 23, 2023 (view filing)9:00 PM ET | Jan 19-20 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −214.2K | $27.13 | −$5.81M | −1.1%19.4M after | 4 lots |
| Jan 25, 2023 (view filing) | Jan 24 | 1 day | Pang PhillipChief Medical Officer | SSale | −30.0K | $30.00 | −$900.0K | −17.2%144.0K after | |
| Jan 25, 2023 (view filing)9:00 PM ET | Jan 23 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −36.5K | $28.34 | −$1.03M | −0.2%19.3M after | 2 lots |
| Feb 1, 2023 (view filing)9:00 PM ET | Jan 30-31 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −152.8K | $29.46 | −$4.50M | −0.8%19.2M after | 4 lots |
| Feb 3, 2023 (view filing)9:00 PM ET | Feb 1-2 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −148.6K | $29.42 | −$4.37M | −0.8%19.0M after | 3 lots |
| Feb 7, 2023 (view filing)9:00 PM ET | Feb 3-6 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −114.0K | $30.21 | −$3.44M | −0.6%18.9M after | 4 lots |
| Feb 9, 2023 (view filing) | Feb 8 | 1 day | Sato Vicki LDirector | SSale | −17.9K | $28.37 | −$508.3K | −1.3%1.35M after | 2 lots |